Illness	Number of cases
Parkinson disease (G20.11)	802
Parkinson disease (G20.10)	420
Parkinson disease (G20.00)	77
Parkinson disease (G20.01)	45
Parkinson disease (G20.21)	45
Other degenerative diseases of basal ganglia - Progressive supranuclear ophthalmoplegia Steele-Richardson-Olszewski (G23.1)	32
Other degenerative diseases of basal ganglia - Striatonigral degeneration (G23.2)	27
Secondary parkinsonism - Vascular parkinsonism (G21.4)	16
Parkinson disease (G20.20)	15
Other degenerative diseases of basal ganglia (G23.3)	8

Top 10 treatments

Treatment	Number
Measurement of the electrical activity of the heart without a tube (catheter) inserted into the heart via an artery (1-266.x)	1.649
Assessment of perception and behaviour by means of standardised tests (1-902.0)	1.490
Measurement of smell and taste (1-247)	1.443
Examination of nerve conduction - ENG (1-206)	1.372
Other examination of the function of the nervous system (1-20a.33)	1.305
Treatment of physically or functionally induced disorders of speech, language, the voice or swallowing (9-320)	1.129
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.2)	752
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.30)	545
Interdisciplinary management other chronic illnesses (8-97d.1)	472
(9-984.8)	363

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
4	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
4	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
4	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility